ADA-auriculoacupuncture as a symptomatic treatment for agitation in people with dementia:a randomized, controlled, rater-blind pilot study
- Conditions
- agitation in people with dementia
- Registration Number
- DRKS00017703
- Lead Sponsor
- Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klinikum München, LMU München
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
age at least 65 years;
- dementia, diagnosed by a physician;
- clinical agitation in 4 weeks prior to inclusion;
- written consent by the patient if capacity for consent is given or written consent by the authorized proxy if an authorized proxy exists.
- dermal or chondral ear defects that would prevent an acupuncture treatment;
- anticoagulation with phenprocoumon, warfarine or multiple anticoagulatory treatment;
- elevated risk of bleeding due to coagulatory defects (e.g. hemophilia);
- clinically permanent severe agitation, indicating that an acupuncture treatment might be impossible;
- known physical resistance in needle-involving situations (e.g. blood collection);
- physical resistance of the person during the compliance test (ear disinfection test);
- acupuncture treatment during 4 weeks prior to preliminary medical exam;
- vagal nerve stimulation treatment during 4 weeks prior to preliminary medical exam.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method